MetaVia Inc.
MTVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001638287
No open-market purchases or sales by MetaVia Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $414.0K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in MetaVia Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −12 vs. Q2 2022
- Shares held
- 16.1K
- −1.21M (−98.7%) vs. Q2 2022
- Total value
- $219.5K
- −$362.5K (−62.3%) vs. Q2 2022
- New holders
- 1
- 1 more added
- Sold out
- 13
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $414.0K |
| Q1 2026 | 12 | $80.4K |
| Q4 2025 | 11 | $306.0K |
| Q3 2025 | 16 | $425.2K |
| Q2 2025 | 15 | $171.2K |
| Q1 2025 | 14 | $1.10M |
| Q4 2024 | 15 | $1.84M |
| Q3 2024 | 13 | $3.47M |
| Q2 2024 | 12 | $4.32M |
| Q1 2024 | 13 | $398.3K |
| Q4 2023 | 8 | $245.4K |
| Q3 2023 | 14 | $193.6K |
| Q2 2023 | 8 | $38.8K |
| Q1 2023 | 9 | $73.8K |
| Q4 2022 | 17 | $1.00M |
| Q3 2022 | 9 | $219.5K |
| Q2 2022 | 21 | $582.0K |
| Q1 2022 | 20 | $1.20M |
| Q4 2021 | 20 | $2.06M |
| Q3 2021 | 18 | $2.79M |
| Q2 2021 | 27 | $2.86M |
| Q1 2021 | 31 | $6.56M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding MetaVia Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 11,393 | $156.0K | 0.00% | −482,602−97.7% | Reduced |
| UBS Group AG | 3,765 | $52.0K | 0.00% | +699+22.8% | Added |
| BlackRock Inc. | 707 | $9.00K | 0.00% | −20,550−96.7% | Reduced |
| Tower Research Capital LLC (TRC) | 178 | $2.00K | 0.00% | −14,542−98.8% | Reduced |
| BNP Paribas Arbitrage, SA | 38 | $520 | 0.00% | +38 | New |
| Bank of America Corp | 8 | $0 | 0.00% | −232−96.7% | Reduced |
| Wells Fargo & Company | 3 | $0 | 0.00% | −353−99.2% | Reduced |
| Morgan Stanley | 2 | $0 | 0.00% | −74−97.4% | Reduced |
| Group One Trading, L.P. | 3 | $0 | 0.00% | −435−99.3% | Reduced |
| Murchinson Ltd. | 0 | $0 | 0.00% | −205,256−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −108,541−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −93,376−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −65,290−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −59,356−100.0% | Sold out |
| Mount Yale Investment Advisors, LLC | 0 | $0 | 0.00% | −57,425−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −40,496−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −24,056−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −17,155−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −16,558−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −3,044−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |